Since dorzagliatin is supposed to “repair” patients’ damaged insulin regulating function, it can potentially be a “cure” for some patients, who will not need the drug after certain period of intake. Existing drugs only lower3 blood sugar when the need arises.
SCMP
Eric Ng - Why are investors offloading Hua Medicine stock which is close to launching a novel diabetes drug?
No comments:
Post a Comment